Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Plant natriuretic peptides (PNPs) are hormones that have been extracted from many different species, with the PNP (AtPNP-A) being the most studied among them. AtPNP-A is a signaling molecule that consists of 130 residues and is secreted into the apoplast, under conditions of biotic or abiotic stress. AtPNP-A has distant sequence homology with human ANP, a protein that forms amyloid fibrils in vivo. In this work, we investigated the amyloidogenic properties of a 34-residue-long peptide, located within the AtPNP-A sequence, in three different pH conditions, using transmission electron microscopy, X-ray fiber diffraction, ATR FT-IR spectroscopy, Congo red and Thioflavin T staining assays. We also utilize bioinformatics tools to study its association with known plant amyloidogenic proteins and other proteins. Our results reveal a new case of a pH-dependent amyloid forming peptide in , with a potential functional role.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747288PMC
http://dx.doi.org/10.3390/plants11010009DOI Listing

Publication Analysis

Top Keywords

plant natriuretic
8
natriuretic peptide
4
peptide active
4
active domain
4
domain forms
4
forms amyloid-like
4
amyloid-like fibrils
4
fibrils ph-dependent
4
ph-dependent manner
4
manner plant
4

Similar Publications

Luteolin alleviates right ventricular hypertrophy in high altitude pulmonary hypertension rats by regulating PI3K/AKT/mTOR signalling pathway.

Eur J Pharmacol

September 2025

Research Center for High Altitude Medicine, Key Laboratory for High Altitude Medicine (Ministry of Education), Laboratory for High Altitude Medicine of Qinghai Province, Qinghai University, Xining, 810001, China; Clinical Medical College & Affiliated Hospital of Chengdu University, Chengdu, 610106,

High altitude pulmonary hypertension (HAPH) is a chronic high-altitude disease caused by chronic hypoxia. Protecting right ventricular (RV) structure and function constitutes a key strategy for improving HAPH prognosis. Luteolin, a plant-derived flavonoid with cardiovascular protective properties, has been shown to reduce pulmonary artery pressure by improving vascular remodelling in HAPH.

View Article and Find Full Text PDF

Background: Dietary patterns currently recommended for cardiovascular health often emphasize the consumption of plant foods.

Methods: We included 7,708 participants from the National Health and Nutrition Examination Survey 1999-2004 aged ≥20 years who were not pregnant and did not have a self-reported history of cardiovascular disease. Dietary intake was assessed using a 24-hour dietary recall.

View Article and Find Full Text PDF

Cardiovascular and Renal Outcomes Following Repeated Naringenin Exposure in Normotensive and Hypertensive Rats.

Pharmaceuticals (Basel)

June 2025

Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Universidade do Vale do Itajaí (Univali), Itajaí 88302-901, Brazil.

: Systemic arterial hypertension is one of the leading global health concerns, significantly increasing the risk of cardiovascular and kidney diseases, including nephrolithiasis. The treatment, still far from ideal, is constantly undergoing new alternatives. In this context, medicinal plants rich in flavonoids, such as naringenin-a compound found in citrus fruits-have gained attention for their potential diuretic, nephroprotective, and blood pressure-lowering effects.

View Article and Find Full Text PDF

Emerging investigations have indicated that many plant polysaccharides may be beneficial for treating metabolic diseases. To date, the therapeutic efficacy and potential toxicity of polysaccharides extracted from () remain unexplored. This study investigated the in vivo acute and subacute oral toxicological profiles of the highest doses of bioactive polysaccharides (CNBP) extracted from the leaves using conventional toxicity methods.

View Article and Find Full Text PDF

[Integrated multiomics reveal mechanism of Aidi Injection in attenuating doxorubicin-induced cardiotoxicity].

Zhongguo Zhong Yao Za Zhi

April 2025

State Key Laboratory of Functions and Applications of Medicinal Plants/Guizhou Provincial Key Laboratory of Pharmaceutics,Guizhou Medical University Guiyang 550004, China Engineering Research Center for the Development and Application of Ethnic Medicine and TCM(Ministry of Education),Guizhou Provinci

The combination of Aidi Injection(ADI) and doxorubicin(DOX) is a common strategy in the treatment of cancer, which can achieve synergistic anti-tumor effects while attenuating the cardiotoxicity caused by DOX. This study aims to investigate the mechanism of ADI in attenuating DOX-induced cardiotoxicity by multi-omics. DOX was used to induce cardiotoxicity in mice, and the cardioprotective effects of ADI were evaluated based on biochemical indicators and pathological changes.

View Article and Find Full Text PDF